 |
|
 |
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 Division of Neonatology, Albert Einstein Medical Center, Philadelphia
2 Division of Neonatology, Department of Pediatrics, Albert Einstein Medical Center, Philadelphia
3 Division of Neonatology, Department of Pediatrics, Albert Einstein Medical Center, Temple University School of Medicine, Philadelphia
4 Department of Pediatrics, Albert Einstein Medical Center, Temple University School of Medicine, Philadelphia
Objective. To evaluate the effectiveness in low birth weight (LBW) infants of the currently recommended immunization schedule for conjugated Haemophilus influenzae type b (HIB) vaccine.
Methods. We quantified antibody responses in 36 preterm infants with a mean birth weight of 1060 g and a mean gestational age of 28 weeks. Infants were immunized with 0.5 mL of HIB vaccine at 2 and 4 months' postnatal age. Specific HIB antibodies were quantified on cord blood, immediately before each immunization and 2 months after the last immunization.
Results. Even though the geometric mean titers increased significantly during the study period, they were still markedly lower than values reported in term infants. After the second immunization, only 24 infants (67%) attained antibody concentrations of more than 0.25 µg/mL, defined as seropositivity. Also, only 53% of infants achieved antibody concentrations of more than 1.0 µg/mL compared with 92% as reported in term infants. Stepwise logistic regression identified gestational age of 27 weeks or less and the amount of intravenous immunoglobulin received as the significant variables influencing the antibody response after the first immunization. The incidence of side effects was negligible.
Conclusions. We conclude that LBW infants, and especially those born at 27 or less weeks' gestation, do not respond as effectively to the HIB vaccine. We speculate that reevaluation of the current immunization schedule may be required for very LBW infants.
Submitted on March 17, 1994
This article has been cited by other articles:
 |
|
 |
|
  K. Kaur, S. Chowdhury, N. S. Greenspan, and J. R. Schreiber Decreased expression of tumor necrosis factor family receptors involved in humoral immune responses in preterm neonates Blood, October 15, 2007; 110(8): 2948 - 2954. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. T. D'Angio, P. A. Boohene, A. Mowrer, S. Audet, M. A. Menegus, D. S. Schmid, and J. A. Beeler Measles-Mumps-Rubella and Varicella Vaccine Responses in Extremely Preterm Infants Pediatrics, March 1, 2007; 119(3): e574 - e579. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Omenaca, J. Garcia-Sicilia, P. Garcia-Corbeira, R. Boceta, and V. Torres Antipolyribosyl Ribitol Phosphate Response of Premature Infants to Primary and Booster Vaccination With a Combined Diphtheria-Tetanus-Acellular Pertussis-Hepatitis B-Inactivated Polio Virus/Haemophilus influenzae Type b Vaccine Pediatrics, January 1, 2007; 119(1): e179 - e185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Bonhoeffer, C-A Siegrist, and P T Heath Immunisation of premature infants. Arch. Dis. Child., November 1, 2006; 91(11): 929 - 935. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Omenaca, J. Garcia-Sicilia, P. Garcia-Corbeira, R. Boceta, A. Romero, G. Lopez, and R. Dal-Re Response of Preterm Newborns to Immunization With a Hexavalent Diphtheria-Tetanus-Acellular Pertussis-Hepatitis B Virus-Inactivated Polio and Haemophilus influenzae Type b Vaccine: First Experiences and Solutions to a Serious and Sensitive Issue Pediatrics, December 1, 2005; 116(6): 1292 - 1298. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Baley and E. G. Leonard The Immunologic Basis for Neonatal Immunizations NeoReviews, October 1, 2005; 6(10): e463 - e470. [Full Text] [PDF]
|
|
|
|
|
|
R K Smith and A C Elias-Jones Risk of life threatening apnoea after immunisation Arch. Dis. Child., April 1, 2005; 90(4): 436 - 437. [Full Text] [PDF]
|
|
|
|
|
|
M. J Robinson, C. Heal, E. Gardener, P. Powell, and D. G. Sims Antibody Response to Diphtheria-Tetanus-Pertussis Immunization in Preterm Infants Who Receive Dexamethasone for Chronic Lung Disease Pediatrics, April 1, 2004; 113(4): 733 - 737. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. N. Saari and and Committee on Infectious Diseases Immunization of Preterm and Low Birth Weight Infants Pediatrics, July 1, 2003; 112(1): 193 - 198. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Allergy, immunity, and infection Arch. Dis. Child., April 1, 2003; 88(90001): A54 - 57. [Full Text] [PDF]
|
|
|
|
|
|
P T Heath, R Booy, J McVernon, J Bowen-Morris, H Griffiths, M P E Slack, A C Moloney, M E Ramsay, and E R Moxon Hib vaccination in infants born prematurely Arch. Dis. Child., March 1, 2003; 88(3): 206 - 210. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P Clarke, P J Powell, D Goldblatt, and M J Robinson Effect of a fourth Haemophilus influenzae type b immunisation in preterm infants who received dexamethasone for chronic lung disease Arch. Dis. Child. Fetal Neonatal Ed., January 1, 2003; 88(1): F58 - 61. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A. Losonsky, S. S. Wasserman, I. Stephens, F. Mahoney, P. Armstrong, K. Gumpper, S. Dulkerian, D. J. West, and I. H. Gewolb Hepatitis B Vaccination of Premature Infants: A Reassessment of Current Recommendations for Delayed Immunization Pediatrics, February 1, 1999; 103(2): 14e - 14. [Abstract] [Full Text]
|
|
|
|
|
|
R. Khalak, M. E. Pichichero, and C. T. D'Angio Three-year Follow-up of Vaccine Response in Extremely Preterm Infants Pediatrics, April 1, 1998; 101(4): 597 - 603. [Abstract] [Full Text] [PDF]
|
|
 |
||
|
||
Home | My Pediatrics | Journal Information | Current Issue | Past Issues | Subscriptions & Services | Contact Us Click here for faster international access © 1995 American Academy of Pediatrics. All rights reserved. |
||
|
||
